A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures
Status:
Completed
Trial end date:
1996-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of topiramate as an add-on
therapy in epilepsy patients with uncontrolled primary generalized tonic-clonic seizures, who
are taking 1 or 2 standard antiepileptic drugs.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.